Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tumors: A randomized double-blinded placebo-controlled phase II trial.

Authors :: UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
UCL - (SLuc) Service de gastro-entérologie
UCL - (SLuc) Unité d'oncologie médicale
Demols, Anne
Borbath, Ivan
Van den Eynde, Marc
Houbiers, Ghislain
Peeters, Marc
Maréchal, Raphael
Delaunoit, Thierry
Goeminne, Jean Charles.
Laurent, Stéphanie
Holbrechts, Stephane
Paesmans, Marianne
Van Laethem, Jean L.
ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium
UCL - SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
UCL - (SLuc) Service de gastro-entérologie
UCL - (SLuc) Unité d'oncologie médicale
Demols, Anne
Borbath, Ivan
Van den Eynde, Marc
Houbiers, Ghislain
Peeters, Marc
Maréchal, Raphael
Delaunoit, Thierry
Goeminne, Jean Charles.
Laurent, Stéphanie
Holbrechts, Stephane
Paesmans, Marianne
Van Laethem, Jean L.
ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium
Source :: Journal of Clinical Oncology, Vol. 37, no. Suppl 4, p. 345 (2019)
Publication Year :: 2019

Database :: OAIster
Journal :: Journal of Clinical Oncology, Vol. 37, no. Suppl 4, p. 345 (2019)
Notes :: English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1130445150
Document Type :: Electronic Resource

Tools